2,3-dihydrofuro[2,3-b]pyridine compounds
US11214576B2 · kind B2 · utility
0Cited by
4References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2019 |
| Grant date | Jan 4, 2022 |
| Priority date | — |
| Expiry date | Jun 14, 2039 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB21B2265/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a compound of Formula I: wherein R is H or F; or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases, such as Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.